Search All UT System Experts

Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: Joint analysis of data from NCCTG N9831 and NSABP B-31

Edith A. Perez, Edward H. Romond, Vera J. Suman, Jong Hyeon Jeong, Nancy E. Davidson, Charles E. Geyer, Silvana Martino, Eleftherios P. Mamounas, Peter A. Kaufman, Norman Wolmark

Research output: Contribution to journal › Article › peer-review

632 Scopus citations

Fingerprint

Dive into the research topics of 'Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: Joint analysis of data from NCCTG N9831 and NSABP B-31'. Together they form a unique fingerprint.

Medicine & Life Sciences